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a b s t r a c t
The determination of S-nitrosoglutathione (GSNO) levels in biological fluids is controversial, partly due to
the laborious sample handling and multiple pretreatment steps required by current techniques. GSNO
decomposition can be effected by the enzyme gamma-glutamyltransferase (GGT), whose involvement
in GSNO metabolism has been suggested. We have set up a novel analytical method for the selective
determination and speciation of GSNO and its metabolite S-nitrosocysteinylglycine, based on liquid
chromatography separation coupled to on-line enzymatic hydrolysis of GSNO by commercial GGT. In a
post-column reaction coil, GGT allows the specific hydrolysis of the c-glutamyl moiety of GSNO, and
the S-nitrosocysteinylglycine (GCNO) thus formed is decomposed by copper ions originating oxidized
cysteinylglycine and nitric oxide (NO). NO immediately reacts with 4,5-diaminofluorescein (DAF-2)
forming a triazole derivative, which is detected fluorimetrically. The limit of quantitation (LOQc) for
GSNO and GCNO in plasma ultrafiltrate was 5 nM, with a precision (CV) of 1–6% within the
5–1500 nM dynamic linear range.
The method was applied to evaluate the recovery of exogenous GSNO after addition of aliquots to
human plasma samples presenting with different total GGT activities. By inhibiting GGT activity in a time
dependent manner, it was thus observed that the recovery of GSNO is inversely correlated with plasmatic
levels of endogenous GGT, which indicates the need for adequate inhibition of endogenous GGT activity
for the reliable determination of endogenous GSNO.
! 2009 Elsevier Inc. All rights reserved.
Introduction
It is widely accepted that S-nitrosothiols (RSNOs)1 are impor-
tant intermediates in nitric oxide (NO) metabolism, though their
significance in pathophysiological phenomena still remains under
debate. Several methods have been published in recent years, all
including rather aggressive and non-specific decomposition proce-
dures [photolysis, HgCl2, HgCl2/V(III), KI/I2, Cys/KI/Cu(I) etc., liable
to cause undesired interactions with components of biological
matrices[1]. Besides, a major obstacle in assessing reference values
of RSNOs in complex biological matrices is represented by the lack
of consolidated procedures for sampling/storage to preserve RSNO
stability in the pre-analytical step, as well as of validated analytical
methods/protocols and certified reference material [1]. As a conse-
quence, the range of basal RSNO levels reported in various studies
has covered more than three orders of magnitude, between low
nanomolar (<1–62 nM) and low-micromolar/micromolar levels
[1–3].
GGT is a central enzyme for the synthesis and degradation
of GSH [4]. GGT can also cause decomposition of GSNO [5,6],
and the metabolite GCNO is more susceptible than GSNO to
copper ion-catalysed decomposition [7]. Thus, in the presence
of glycylglycine (GG) as acceptor, the following reactions occur
in vitro:
GSNOþ GG!GGT GCNOþ c-GluGG ð1Þ
GCNO!CuðIIÞ NOþ GCox ð2Þ
0003-9861/$ - see front matter ! 2009 Elsevier Inc. All rights reserved.
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1 RSNOs, S-nitrosothiols; GSNO, S-nitrosoglutathione; GGT, gamma-glutamyltrans-
ferase; GCNO, S-nitrosocysteinylglycine; LOQc, limit of quantitation; NO, nitric oxide;
GG, glycylglycine; LC, liquid chromatography; DAF-2, diaminofluorescein; DMSO,
dimethyl sulfoxide; NEM, N-ethylmaleimide; DTPA, diethylentriamine-pentaacetic
acid pentasodium salt; SBC, serine/borate complex; DAD, diode array detector; FD,
fluorimetric detector.
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It was reported that the reaction of Cu(II) with GCNO is fast,
with half-lives of about 5 s, while the reaction with GSNO is 3–4
orders of magnitude slower [7]. By in vitro kinetics analysis we
have recently shown that bovine kidney GGT has a Km value for
GSNO of 0.398 ± 0.031 mM, comparable with the Km value for
GSH (0.4 mM) [8].
In the present study we have set up a new analytical method for
the specific determination and speciation of GSNO and GCNO,
based on liquid chromatography (LC) and an on-line, post-column
reaction system. In the latter, conditions are adjusted for enzy-
matic decomposition of GSNO by commercial bovine kidney GGT
(reaction (1)), fast decomposition of its product GCNO by copper
ions (reaction (2)) [9], and reaction of NO thus formed with 4,5-dia-
minofluorescein (DAF-2) (reaction (3)) [10,11]:
NOþ DAF-2$!DAF-2T ð3Þ
The triazole derivative, DAF-2T, is detected and quantified fluo-
rimetrically. The procedure allowed the separation of GSNO and
GCNO from compounds present in complex matrices and in the
presence of ascorbic acid and uric acid, which are known to inter-
fere with NO detection [12–14]. Besides, data obtained with plas-
ma samples confirmed that a loss of GSNO may occur during
pre-analytical handling when endogenous GGT present is not
inhibited.
Materials and methods
Chemicals
Analytical reagent-grade chemicals were used without further
purification. GGT (G-8040, Type I crude from bovine kidney) and
glycylglycine (GG, G-1002) were purchased from Sigma–Aldrich
(Sigma, Chemical Co., Milan, Italy). Copper sulphate anhydrous
(2791) was purchased from Merck (Laborchimica, Firenze, Italy).
Five millimolar solution of 4,5-Diaminofluorescein (DAF-2) solu-
tion in dimethyl sulfoxide (DMSO) (251510) and its triazole deriv-
ative (DAF-2T, 251510, 0.5 mM in DMSO) were purchased from
Calbiochem (La Jolla CA, USA).
N-ethylmaleimide (NEM, 04259 BioChemika Ultra, P99.0%),
DL-serine (84980), boric acid (B-0252) and diethylentriamine-pen-
taacetic acid pentasodium salt (DTPA, 17969) were purchased from
Fluka (Fluka GmbH, Buchs, Switzerland). 50 mM stock solution of
ethylenediaminetetracetic acid (405501, EDTA disodium salt,
RPE) was purchased from Carlo Erba (Milan, Italy). Phosphate buf-
fer solution (PBS) was prepared from monobasic monohydrate so-
dium phosphate and dibasic anhydrous potassium phosphate (BDH
Laboratory Supplies, Poole, England).
Fresh 0.4 M NEM stock solution was prepared in MilliQ water
daily. 0.4 M serine/borate complex (SBC) stock solution was pre-
pared in 1 M PBS pH 8.0. GGT was prepared in 0.1 M PBS pH 8.0.
0.2 M GG stock solution was prepared in 1 M PBS pH 8.0. CuSO4
was prepared in MilliQ water.
Stock solution of GSNO (N4148, CAS No. 57564-91-7, Sigma)
was prepared in 0.1 M PBS pH 8.0, 0.5 mM DTPA. As such, GSNO
standard solution was stable during the working day (9 h time
tested at room temperature) and for 4 weeks if stored at $80 "C.
S-Nitrosocysteinylglycine (GCNO), S-nitrosocysteine (CysNO)
and S-nitrosohomocysteine (HCysNO) were prepared by reacting
1 M NaNO2 in H2O with 1.1 M thiols in 0.5 M HCl, 0.5 mM EDTA
at 0 "C for 40 min [15]. RSNOs were diluted in 0.1 M PBS pH 8.0,
0.5 mM DTPA and stability was tested before any other use.
Methanol for liquid chromatographic analysis was purchased
from Carlo Erba (Rodano, MI, Italy). Water deionized with a
Milli-Q system (Millipore, Bedford, MA, USA) was used
throughout.
Spectrophotometric analysis
Concentrations of GSNO, CysNO, HCysNO and GCNO in 0.1 M
PBS, pH 8.0, at 21 ± 0.1 "C were calculated from the absorbance at
334 nm [16] by a Beckman DU-600 spectrophotometer.
Fluorimetric analysis
A fluorescence spectrophotometer (Perkin-Elmer LS-45 Lumi-
nescence Spectrophotometer) was used for method optimization.
Slit width was 10 nm for both excitation (kex = 485 nm) and emis-
sion (kem = 515 nm). Measurements were performed in 1 mL, 1 cm
path length cuvette. The concentration of DAF-2 standard solution
used for determinations was optimized between 0.025 and 0.5 lM.
The commercial product DAF-2T gave a calibration curve linear in
the range 1–20 nM (slope = 74.4 ± 1.7, R = 0.9992, N = 5) and a
detection limit of 1 nM.
Measurement of GGT activity
GGT activity was determined by following the hydrolysis of
c-glutamylcarboxy-p-nitroanilide (Glu-cp-NA) as previously
described [17]. Briefly, purified enzyme was incubated with
1 mM Glu-cp-NA and 20 mM GG in PBS (0.1 M, pH 8.0) at 37 "C
and the absorbance increase at 405 nm was monitored. Enzyme
activity was determined using a molar absorption coefficient of
8800 M$1cm$1 for the formation of p-nitroaniline.
Human blood sampling and storage
Plasma aliquots were derived from routine clinical samples
obtained from 13 different in-patients (Inst. of Clinical Physiol-
ogy–CNR, Pisa). Venous blood was collected by venipuncture using
EDTA as anticoagulant. After low-speed centrifugation (1500 g,
10 min) at room temperature, plasma samples were stored at
$20 "C until analysis. One milliliter of plasma was immediately
spiked with 10 lL of 50 mM DTPA stock solution (0.5 mM final
concentration of DTPA in plasma) and 30 lL of 0.4 M NEM stock
solution (12 mM final concentration of NEM). Then, GGT inhibitor
serine/borate complex (SBC; 10 mM final concentration) was
added before GSNO spike or after various intervals incubation time.
The addition of DTPA/NEM/SBC solution avoided losses of GSNO
due to transnitrosation reactions, metal- and enzyme-mediated
decomposition (see Results).
Before analysis, plasma samples were diluted 1:1 in 0.1 M PBS
pH 7.4, 0.5 mM EDTA, loaded onto the sample reservoir of an
Amicon Microcon YM-3 centrifugal filter units (cut-off 3000 Da;
Millipore, Bedford, MA, USA) and centrifuged at 11000g for
90 min at 4 "C, to remove proteins and high molecular weight com-
pounds. Ultrafiltrates were then injected in the chromatographic
system. For the experiments of recovery of spiked RSNO in human
whole blood, RSNOs were added after the addition of DTPA/NEM/
SBC solution.
Instrumental set-up
The HPLC unit consisted of a pump (P4000, ThermoQuest)
equipped with a Rheodyne 7125 injector (Rheodyne, Cotati, CA,
USA), a 100 lL poly(etheretherketone) (PEEK tubing, Upchurch,
Oak Harbor,WA) injection loop and an HPLC column (Gemini RP
C18 250 % 4.6 mm, silica particle size 5 lm, equipped with a Guard
Cartridge KJ0-4282, Phenomenex). The eluent for the chromato-
graphic analysis was 99% 0.02 M PBS pH 6.0/1% methanol (99:1
v/v), flowing in the optimized conditions at 0.8 mL/min. The flow
eluting from HPLC column was monitored between 210 and
650 nm by a UV–visible diode array detector (DAD) equipped with
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a 5 cm path length flow cell (UV6000, ThermoQuest). The effluent
was blended in a low dead-volume mixing-tee with the reaction
solution delivered by a second HPLC pump (Jasco PU2080) at a flow
rate of 0.3 mL/min, containing 140 mU/mL GGT, 0.03 mM copper
sulphate, 1.2 mM GG and 0.37 lMDAF-2 in 0.1 M PBS pH 8.0 (opti-
mized conditions, concentrations in the reaction coil). The enzy-
matic reaction proceeded in the optimized conditions in a PFA
reaction coil of 2.8 ml, corresponding to a treaction = 2.55 min, kept
at the constant temperature of 37 "C in a water bath (Fig. 1). Thus,
the DAF-2T signal was specifically detected by a fluorescence
detector (FL3000, ThermoFinnigan) operating at excitation wave-
length kex = 486 nm and emission wavelength kem = 516 nm.
Fig. 1 shows a detailed schematic of the LC-DAD-FD system
equipped with the post-column reaction system described.
Results
UV spectrophotometric experiments
UV spectrophotometry was used to roughly optimize GG, GGT
and CuSO4 concentrations, prior to optimizing on line reaction con-
ditions (see below). Optimization was performed by a Box-Wilson
central composite design, varying GG in the range 5–20 mM, GGT
in the range 300–1200 mU/mL, and CuSO4 between 50 and
250 lM. Experiments were run in 1 mL cuvettes, in 0.1 M PBS pH
8.0. GG, copper and GGT were added at the established concentra-
tions in the order reported above. Thus, the blank was read in the
spectrophotometer, and GSNOwas added as last component before
starting kinetics data acquisition. By varying the concentration of
GGT and GG, and by evaluating the time-dependent plots of the
absorbance at 334 nm, we found that 525 mU/mL GGT and
4.5 mM GG (final concentrations) were the optimal conditions for
the quantitative decomposition (P95%) of GSNO in about 300 s
at 37 "C. In the absence of copper and chelating agents, transition
metals present as contaminants in the reaction medium decom-
posed GCNO slowly. Increasing concentrations of copper rapidly
decomposed GCNO. When the reaction medium also included
EDTA, GCNO decomposition was not prevented, provided that cop-
per was added in excess with respect to EDTA. A concentration of
100 lM Cu(II) was sufficient for the quantitative decomposition
of 100 lM GSNO in 300 s, in the presence of 525 mU/mL GGT
and 4.5 mM GG. The same experiments performed in the absence
of GGT showed that copper by itself (up to 1.2 mM) did not decom-
pose GSNO in the 300 s observation time (data not shown).
In the operating conditions employed (4.5 mM GG, 0.1 mM
CuSO4, 525 mU/mL GGT), the stability of three other S-nitrosothi-
ols was also verified, GCNO, HcysNO, and CysNO. In the absence
of GGT GSNO was stable, GCNO was instantaneously decomposed,
as previously reported [9], CysNO was instantaneously and fully
decomposed as well, and HCysNO was decomposed by about 75%
(data not shown).
Fluorimetric experiments
GGT-catalysed/copper-mediated GSNO hydrolysis was then
investigated in cuvette by fluorescence spectrometry, in order to
optimize the DAF-2-mediated detection of the product NO. Exper-
iments were run in 1 mL cuvette in 0.1 M PBS pH 8.0. GG, copper
sulphate, GGT and DAF-2 were added at the established concentra-
tion. Thus, blank was obtained (kex = 485 nm, kem = 515 nm) and
GSNO was then added as last component, before starting the kinet-
ics data acquisition.
The GGT-catalysed/copper-mediated decomposition of
0.3 lmol/L GSNO obtained with five different concentrations of
DAF-2 (0.5, 0.3, 0.1, 0.05 and 0.025 lM DAF-2) showed an increase
of fluorescence signal as a function of time, which corresponded to
formation of DAF-2T following the release of NO from GCNO (data
not shown). The reaction was complete for a reaction time
tP 5 min for all the concentrations of DAF-2 considered, as
expected on the basis of spectrophotometric kinetics at 334 nm.
At increasing concentrations of DAF-2 the plateau value F10 (=the
fluorescence signal after 10 min reaction time) increased as well,
indicating an increase of NO detection sensitivity obtained at high-
er DAF-2 concentrations. However, the overlapping of curves
obtained with 0.5 and 0.3 lM DAF-2 clearly indicated that above
0.3 lM DAF-2 the rate of reaction (3) no longer depends on DAF-
2 concentration, but likely on the rate of formation of the interme-
diate N2O3 [10,11]. At higher DAF-2 concentrations (e.g. 0.5 lM)
the blank signal obtained in the absence of GSNO increased as well,
thus affecting the baseline noise signal. Thus, the sensitivity factor
(i.e. the slope of the calibration curve) and the baseline noise,
which is correlated with the concentration detection limit (LODc),
depend on the DAF-2 concentration chosen for the analysis.
Table 1 summarizes the results of data fitting of calibration
curves of GSNO standard solutions performed in cuvette in
0.1 mol L$1 PBS pH 8.0, using three different concentrations of
DAF-2 (0.05, 0.1 and 0.5 lM). The LODc of the method in cuvette
was 5 nM, and the dynamic linear range was 15–200 nM. It was
verified that in the absence of GGT the fluorescence signal did
not increase.
Optimization of the reaction conditions for the determination of GSNO
and GCNO in plasma
Although GGT specificity makes the proposed approach applica-
ble to in-batch measurements of GSNO, the presence in complex
biological matrices (e.g. plasma) of other RSNOs also susceptible
to copper-mediated decomposition would require a double deter-
mination – with/without GGT – in order to determine (by subtrac-
tion) the specific GSNO signal. On the other hand, the set up of a
chromatographic separation – coupled to an on line post-column
reaction system including reactions ()(1)–(3) – would make it
possible to speciate GSNO as well as other RSNOs susceptible to
copper-mediated decomposition. Furthermore, by choosing suit-
able separation conditions the interference by compounds known
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Fig. 1. Schematic diagram of LC-FD system for the determination of GSNO and
other RSNOs.
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to affect the formation of DAF-2T, such as uric, ascorbic and dehy-
droascorbic acids [12–14], would be controlled.
Thus, the HPLC separation/post-column reaction procedure was
adapted and optimized for GSNO analysis in complex biological
matrices. Firstly, the HPLC apparatus coupled to the post-column
reaction system and fluorimetric detector (FD) was operated in
flow injection mode (=without HPLC column). A solution of
commercial GSNO was injected in order to optimize detection con-
ditions: concentration of GGT acceptor GG (ranging 1–20 mmol/L),
Cu(II) (100–800 lmol/L), DAF-2 (0.1–2 lmol/L), GGT (0.2–1.5 U/
mL), as well as temperature of the thermostatic bath.
Subsequently, HPLC/post-column reaction system/FD in the
normal configuration mode (=with the HPLC column inserted
between the injection valve and the DAD, Fig. 1), was used to opti-
mize the flow rate of HPLC eluent and post-column reaction solu-
tion, and the length of the PFA reaction coil. Parameters were
chosen in order to maximize the GSNO signal and minimize the
peak width at half height (W1/2). This was obtained (i) by limiting
the post-column dilution of reactants, and (ii) by increasing the
post-column reaction time. A 2.7:1 ratio between HPLC eluent flow
and post column solution flow gave optimal results. A flow of
0.8 mL/min was suitable for the separation of GSNO and the other
RSNOs (see below). A flow of 0.3 mL/min was chosen for the post-
column reaction. Fig. 2A shows the LC-FD chromatograms obtained
by injecting a fixed concentration of GSNO without post-column
reaction coil or with PFA reaction coils of various lengths, corre-
sponding to increasing reaction times (considering a total flow in
the reaction coil of 1.1 mL/min). Fig. 2B shows the normalized
slope of GSNO calibration curve (left y axis) and the W1/2 values
(right y axis) as a function of the reaction time.
The slope values of calibration curves reflected the kinetics
obtained in experiments in cuvette. W1/2 values were linear as a
function of reaction time, as expected. We chose a reaction coil
of 2.8 mL, which gave a good sensitivity factor (GSNO was decom-
posed by GGT by about 65–70%) and a W1/2 value compatible with
HPLC separation of all RSNOs studied.
Table 2 summarizes values of all post-column reaction parame-
ters, optimized for GSNO determination by LC-DAD-FD. Concentra-
tions shown are those in the reaction coil when considering a 3.7
dilution factor, due to the mixing of HPLC flow (0.8 mL/min) with
post-column reaction solution (0.3 mL/min).
As discussed above, Cu(II) can rapidly decompose also CysNO
and HCysNO. Thus, in the optimized conditions listed in Table 2,
the four RSNOs (GSNO, GCNO, CysNO and HCysNO) could be
efficiently determined by the method proposed. Fig. 3 shows the
LC-FD chromatogram of a mixture of CysNO, HCysNO, GCNO and
GSNO solutions. We verified that sodium nitrite and nitrate
solutions injected at mM concentrations gave no fluorescence
signal (not shown).
Further determinations were performed in presence or absence
of GGT in order to verify the selectivity of GGT reaction as to GSNO.
In the absence of GGT, GSNO gave a peak about 1/4 of the one ob-
tained in the presence of GGT (data not shown), indicating some de-
gree of not GGT-related GSNO decomposition. This effect may be
produced by Cu(II) being simultaneously present in the reaction
medium with GG (required as acceptor substrate for GGT) and
DAF-2. It is known in fact that formation of adducts with various
ligands, including amino acids [18] and DAF-2 itself [16,17], can al-
ter the redox potential of transition metals, often making them
more reactive.
Recovery of GSNO from plasma
Fig. 4 shows typical LC-FD and UV absorbance chromatograms
of plasma ultrafiltrates. Spikes of RSNOs were added to blood after
Table 1
Fitting parameters of the linear part of GSNO calibration curves obtained at three
different DAF-2 concentrations (50, 100 and 500 nM).
[DAF-2] (nM) Slope(Volts nM$1) Intercept (Volts) N R DLRa (nM)
50 1.41 ± 0.09 10.0 ± 5.7 7 0.9966 15–200
100 2.66 ± 0.09 15.1 ± 2.2 8 0.9948 15–200
500 4.87 ± 0.05 66.7 ± 2.5 7 0.9961 15–200
a Dynamic linear range.
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Fig. 2. Optimization of GGT/Cu++/DAF-2-mediated GSNO determination. (A) LC-FD
chromatograms obtained by injecting a 330 nM GSNO with no post-column
reaction coil or PFA reaction coils of various length: (a) no reaction coil, (b)
1.2 mL, (c) 1.8 mL, (d) 2.8 mL, (e) 4.6 mL, (f) 6.1 mL. Operating conditions: 1.2 mM
GG, 0.37 lM DAF-2, 140 mU/mL GGT, 0.03 mM Cu(II), HPLC flow 0.8 mL/min, post-
column reactant 0.3 mL/min (concentrations in the reaction coil). (B) Normalized
slope of GSNO calibration curve (left y axis) and W1/2 values (right y axis) as a
function of the post-column reaction time.
Table 2
Optimized values of all parameters for the determination of GSNO and RSNO by HPLC
coupled to the post-column reaction system and fluorometric detector.
Parameter Optimized value
GG concentration 1.2–4.5 mMa
Cu(II) concentration 0.03–0.250 mM
DAF-2 concentration 0.37 lM
GGT concentration 140 mU/mL
HPLC flow 0.8 mL/min
Post-column reaction solution flow 0.3 mL/min
PFA reaction coil length 2.8 ml
Temperature of the thermostatic bath 37–41 "C
a We indicated a range for several parameters that can be varied without
affecting significantly the S/N ratio. The sensitivity factor has to be calculated in the
chosen reaction conditions.
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addition of the stabilizing NEM/DTPA/SBC solution, required to
avoid losses due to transnitrosation reactions and metal- and/or
GGT-mediated GSNO decomposition.
Table 3 summarizes the results of fitting of RSNOs calibration
curves obtained in buffer and analyte addition curve in plasma,
in the operating conditions of Table 2, in the 5–1500 nM concen-
tration range. Recovery experiments of RSNOs spiked in plasma
evidenced a good recovery and linear analyte addition curves for
GSNO (98.6%) and GCNO (99.5%) in the 5–1500 nM range. The limit
of quantitation (LOQc) of GSNO and GCNO of the proposed method
was 5 nM, with a precision (CV%) of 1.4–5.7% for GSNO and 1–5.8%
for GCNO within the dynamic linear range (5–1500 nM) at 0.37 lM
DAF-2 concentration in the post-column reaction coil. LOQc was
calculated on the basis of the signal to noise ratio of baseline noise
and the slope of calibration curves, and determined experimentally
by analysing GSNO and GCNO.
Recoveries of CysNO and HCysNO were instead significantly
lower (40–60%) and analyte addition curves were exponential,
showing lower recoveries at lower concentrations (5–50 nM) and
higher recoveries at higher concentrations (50–1500 nM). Further-
more, the LOQc value determined experimentally for both CysNO
and HCysNO was 20 nM. Such low recoveries of CysNO and
HCysNO may be due to interference with NO/DAF-2 reaction by
ascorbic, dehydroascorbic and uric acids [12–14], which eluted
simultaneously to CysNO (ascorbic and dehydroascorbic acid)
and HCysNO (uric acid) (Fig. 4), taking into account the shift due
to post-column reaction time.
Recovery experiments of RSNOs spiked in plasma (approx.
100 nM final conc.) showed that GSNO and GCNO were stabile in
plasma stored at $80 "C up to 3 days (recoveries P85%), while
after 1 week the recovery was &50%. Spiked CysNO and HCysNO
were unstable: after 24 h the recovery was less than 50%. In plasma
ultrafiltrate RSNOs were stable only during the working day. Thus,
while GSNO and GCNO can be accurately determined in plasma
ultrafiltrate by the LC-FD method, separation and detection of Cys-
NO and HCysNO is not possible in plasma, though potentially fea-
sible in simpler matrices.
Hydrolysis of GSNO by endogenous plasmatic GGT
The good separation of GCNO and GSNO, their good recoveries
and determination limit in plasma allowed us to correlate the sta-
bility of spiked GSNO with the endogenous content of GGT. In all
blood samples used, DTPA and NEM were added before GSNO
spike. The metal chelator DTPA should avoid RSNOs losses due to
metal-catalysed decomposition [9]. Alkylation by NEM is able to
block the reactivity of –SH groups in about 20 s at neutral pH at
room temperature [19]. The addition of NEM to plasma samples
should therefore prevent artifactual formation of RSNOs due to
transnitrosation reactions from proteins (basically nitroso-albu-
min) [20] and thiols (in particular GSH) present at micromolar con-
centration levels in plasma [21]. Moreover, if not blocked by NEM,
reduced thiols could reduce adventitious metals present in biolog-
ical samples: in particular, Cu(I) originating from reduction of
Cu(II) could catalyse the decomposition of GSNO [7]. Fig. 5 shows
an example of LC-FD chromatogram of human plasma spiked with
60 nM GSNO, and analysed after allowing increasing times before
GGT inhibition (=addition of SBC: at 0, 1, 5 and 10 min). T = 0
was evaluated by adding SBC before the GSNO spike.
As can be seen, when increasing times were allowed before
addition of SBC to plasma samples, proportionally lower GSNO
recoveries were obtained, while amounts of detectable GCNO cor-
respondingly increased.
From the areas of chromatographic peaks of GCNO
(tR = 11.90 min) and GSNO (tR = 12.73 min) and their respective
calibration curves, in each sample it was possible to determine at
different times the concentrations of residual GSNO and GCNO
originated by GGT activity (reaction (1)). Data indicate that
depending on the addition time of GGT inhibitor SBC, recoverable
GSNO progressively decreased, along with a corresponding
increase of GCNO. Fig. 6 shows data obtained with four representa-
tive plasma samples (out of 13 examined), characterized by differ-
ent GGT activities. RSNO concentration was normalized with
respect to the GSNO concentration added (60 nM). At t = 0 the
recovery of GSNO was quantitative (97 ± 5%), while at later times
GSNO was converted into GCNO more and more quickly, in corre-
lation with increasing plasma GGT levels.
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chromatograms of CysNO, HCysNO, GCNO and GSNO obtained by using the 2.8 mL
reaction coil: 115 nM CysNO, 350 nM HCysNO, 80 nM GCNO and 30 nM GSNO.
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Fig. 4. Recovery of different RSNOs exogenously added to plasma. LC-DAD-FD
chromatograms (trace a) and UV absorbance chromatogram at 254 nm (trace b) of a
plasma ultrafiltrate sample obtained from blood spiked with 600 nM CysNO,
150 nM HCysNO, 100 nM GCNO and 180 nM GSNO. RSNO concentration found was
310 nM CysNO (recovery 51%), 70vnM HCysNO (recovery 47%), 106 nM GCNO
(recovery 106%) and 170 nM GSNO (recovery 94%).
Table 3
Fitting parameters of RSNO calibration curves in 0.1 M PBS pH 8, 0.5 mM DTPA and
analyte addition curves in plasma in the optimized operating conditions ofTable 2.
RSNO tR (min) Slope (f.u. min nM$1) R2 N
Buffer
GSNO 12.74 2.77 ± 0.002 0.9999 10
CNOG 11.62 4.16 ± 0.005 0.9999 10
CysNO 7.16 2.80 ± 0.002 0.9999 10
HCysNO 9.19 1.91 ± 0.005 0.9999 10
Plasma
GSNO 12.63 2.73 ± 0.011 0.9999 9
CNOG 11.69 4.16 ± 0.005 0.9999 7
CysNO 6.89 Not linear – –
HCysNO 8.13 Not linear – –
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Fig. 7 shows the percentage of residual GSNO found in 13 plas-
ma samples after 5 and 10 min with respect to the total GSNO
spiked, as a function of plasma GGT activity.
An inverse correlation was observed between plasma GGT
activities and percentages of recovered GSNO (linear correlation
parameters after 5 min: intercept 87 ± 4%; slope = $0.18 ± 0.02;
R2 = 0.8696). A positive correlation was found, instead, between
plasma GGT activity and the formation of GCNO (linear correlation
parameters after 10 min: slope = 0.23 ± 0.03; R2 = 0.8021) (data not
shown). The concentration ([GSNO] + [GCNO]) over 10 min was not
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Fig. 5. Interference of endogenous GGT with GSNO determination (I). LC-FD
chromatograms of human plasma stabilized by NEM/DTPA, spiked with 60 nM
GSNO, and analysed after allowing increasing times before GGT inhibition (=addi-
tion of SBC: at 0, 1, 5 and 10 min). T = 0 was evaluated by adding the SBC before the
GSNO spike. The sample shown contained 114 U/L total GGT. GSNO recovery at t = 0
was here 93% taking into account the 1:1 dilution factor of plasma before
ultracentrifugation.
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Fig. 7. Interference of endogenous GGT with GSNO determination (III). Recovery of
GSNO after 5 (closed circles) and 10 min GGT inhibition time (open circles), as a
function of basal GGT activities present in plasma. Recovery was reported as
percentage of the concentration of GSNO found over the total amount spiked. Linear
correlation parameters after 5 min: intercept 87 ± 4%; slope = $0.18 ± 0.02;
R2 = 0.8696; linear correlation after 10 min: intercept 75 ± 6%; slope = $0.17 ± 0.03;
R2 = 0.7410.
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significantly different from the concentration of spiked GSNO, thus
indicating a quantitative conversion of GSNO into GCNO.
Discussion
The results of the present study highlight a fundamental aspect
to be considered in GSNO research, i.e. the patho-physiological role
of endogenous GGT activity possibly (and variably) present in
samples. Data reported in a previous paper from our laboratory,
concerned with the kinetics of GGT with respect to GSNO as a sub-
strate and glycylglycine as acceptor co-substrate [8], suggested
that plasmatic GGT can be a factor in catabolism of GSNO in blood,
where numerous endogenous, physiological acceptor co-substrates
are available. Altogether our observations are of high relevance as
far as GSNO determination: if – besides the inhibition of transni-
trosation reactions and metal-induced decomposition – endoge-
nous GGT activity is not efficiently inhibited during sampling
(pre-analytical step), the analyte may be lost during the following
1–10 min, directly depending on the levels of GGT present in plas-
ma. This observation may explain the elusiveness of GSNO deter-
mination reported in the literature, despite the significant
methodological advances achieved over the recent years.
Thus, SBC at the indicated concentration of 10 mM should be
used during blood sampling in order to avoid GGT-related GSNO
loss, as previously envisaged [22]. Immediate and efficient GGT
inhibition is however a more complex issue than apparent. SBC ali-
quots should perhaps be prepared in ad hoc sampling vessels, pos-
sibly of the vacuum-type. Using the present method or another
recently published by us [22], plasma GSNO concentrations were
found to range in between 30 and 300 nM; these data are however
to be regarded as preliminary, and subject to confirmation. More-
over, a further aspect liable to affect determination is given by pos-
sible haemolysis: even minimal levels could in fact contribute
unpredictable amounts of erythrocytic GSNO to the measured val-
ues. Studies are in progress in our laboratory in order to investigate
these points comprehensively.
In conclusion, a liquid chromatographic system coupled with a
post column injection system delivering a buffer solution contain-
ing GGT, GG, copper and DAF-2 allowed us to fluorimetrically
determine and speciate GSNO and other RSNOs in plasma ultrafil-
trate. The idea of using GGT as a reagent to promote the on line
hydrolysis of GSNO into GCNO, which in turn is labile to copper-
mediated decomposition, represents a novel approach to the long
debated analytical problem of specific GSNO determination in bio-
logical samples. GSNO and GCNO were determined with a LOQc of
5 nM, a precision (CV) of 1–6% in the 5–1500 nM dynamic linear
range, and a recovery 98.6% (GSNO) and 99.5% (GCNO) in plasma
ultrafiltrate. The method allowed the appreciation of a critical
aspect never investigated before, i.e. the direct interference of
(endogenous) GGT activity with detectable GSNO levels. Last but
not least, the method has the advantage of using reagents by far
less toxic or environmentally hazardous as compared to HgCl2
salts, generally used in current procedures for RSNO decomposi-
tion in the 0.1–0.2 mM concentration range.
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